Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"Douglas CDMO","sponsor":"Upsher-Smith Laboratories","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Upsher-Smith Launches Isotretinoin Capsules","therapeuticArea":"Dermatology","highestDevelopmentStatus":"Approved","country":"NEW ZEALAND","productType":"Small molecule","productStatus":"Approved","date":"June 2021","url1":"","url2":"","graph1":"Dermatology","graph2":"Approved"},{"orgOrder":0,"company":"Douglas CDMO","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107","therapeuticArea":"Psychiatry\/Psychology","highestDevelopmentStatus":"Phase II","country":"NEW ZEALAND","productType":"Small molecule","productStatus":"New Molecular Entity","date":"January 2023","url1":"","url2":"","graph1":"Psychiatry\/Psychology","graph2":"Phase II"},{"orgOrder":0,"company":"Douglas CDMO","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Trial Data Suggests Major Breakthrough in Treatment Resistant Depression","therapeuticArea":"Psychiatry\/Psychology","highestDevelopmentStatus":"Phase II","country":"NEW ZEALAND","productType":"Small molecule","productStatus":"Approved","date":"June 2021","url1":"","url2":"","graph1":"Psychiatry\/Psychology","graph2":"Phase II"}]

    Find Clinical Drug Pipeline Developments & Deals by Douglas Pharmaceuticals Ltd

    Menu

    Douglas Pharmaceuticals Ltd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              Douglas CDMO

              Contact Supplier
              • Development Update
              Virtual BoothDouglas CDMO develops, manufactures, and packs various dosage forms, and provides regulatory support for international distribution.
              Contact Supplier Contact Supplier
              Flag New Zealand
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107

              Details:

              R-107, an oral extended-release dose of racemic ketamine being developed as add-on or monotherapy for treatment resistant depression (TRD). It has demonstrated a significant antidepressant effect with maintenance of response at 3 months, high compliance dosing.

              Lead Product(s): Ketamine Hydrochloride

              Therapeutic Area: Psychiatry/Psychology Product Name: R-107

              Highest Development Status: Phase II Product Type: Small molecule

              Partner/Sponsor/Collaborator: Not Applicable

              Deal Size: Not Applicable Upfront Cash: Not Applicable

              Deal Type: Not Applicable January 26, 2023

              Douglas CDMO

              BIO Int. Convention

              Attending

              envelop Contact Supplier

              Douglas CDMO

              Contact Supplier
              • Development Update
              Virtual BoothDouglas CDMO develops, manufactures, and packs various dosage forms, and provides regulatory support for international distribution.
              Contact Supplier Contact Supplier
              Flag New Zealand
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Upsher-Smith Launches Isotretinoin Capsules

              Details:

              Upsher-Smith's product is AB2-rated to the branded product, Absorica® (isotretinoin) capsules. Isotretinoin capsules are a generic version of ABSORICA® indicated for the treatment of severe recalcitrant nodular acne.

              Lead Product(s): Isotretinoin

              Therapeutic Area: Dermatology Product Name: Isotretinoin-Generic

              Highest Development Status: Approved Product Type: Small molecule

              Recipient: Upsher-Smith Laboratories

              Deal Size: Not Applicable Upfront Cash: Not Applicable

              Deal Type: Not Applicable June 25, 2021

              Douglas CDMO

              BIO Int. Convention

              Attending

              envelop Contact Supplier

              Douglas CDMO

              Contact Supplier
              • Development Update
              Virtual BoothDouglas CDMO develops, manufactures, and packs various dosage forms, and provides regulatory support for international distribution.
              Contact Supplier Contact Supplier
              Flag New Zealand
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Trial Data Suggests Major Breakthrough in Treatment Resistant Depression

              Details:

              R-107 (extended-release oral dose of ketamine) act as a blocks the NMDA receptor and it is investigated for the treatment of treatment resistant depression.

              Lead Product(s): Ketamine Hydrochloride

              Therapeutic Area: Psychiatry/Psychology Product Name: R-107

              Highest Development Status: Phase II Product Type: Small molecule

              Partner/Sponsor/Collaborator: Not Applicable

              Deal Size: Not Applicable Upfront Cash: Not Applicable

              Deal Type: Not Applicable June 15, 2021

              Douglas CDMO

              BIO Int. Convention

              Attending

              envelop Contact Supplier

              Douglas CDMO
              Send me more info on How To Grow My Business Digitally?
              Post Enquiry
              POST ENQUIRY